505592 — Shreekrishna Biotech Share Price
Last trade - 00:00Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | n/a | ||
| Price to Tang. Book | n/a | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | n/a | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -0.02% | ||
| Return on Equity | -0.04% | ||
| Operating Margin | n/a | ||
Financial Summary
| Year End 31st Mar | Unit | 2014 | 2015 | 2016 | 2017 | 2018 | 2019E | 2020E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | IN₹m | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Shreekrishna Biotech Limited is an India-based company. The Company is focused in the business of biotechnology. The Company is engaged in trading and manufacturing activities.
Directors
- Last Annual
- March 31st, 2018
- Last Interim
- June 30th, 2018
- Incorporated
- February 19th, 1983
- Public Since
- January 1st, 1970
- Sector
- Biotechnology & Medical Research
- Industry
- Healthcare
- Exchange
- Bombay Stock Exchange
- Shares in Issue
- 9,851,500
- Address
- MUMBAI, 400028
- Web
- Phone
- +91 2226000587
- Auditors
- Jain Vijay & Associates
Upcoming Events for 505592
Similar to 505592
Chemo Pharma Laboratories
Bombay Stock Exchange
Indo US Bio-Tech
Bombay Stock Exchange
Jeevan Scientific Technology
Bombay Stock Exchange
Shree Ganesh Remedies
Bombay Stock Exchange
Transgene Biotek
Bombay Stock Exchange
FAQ
As of Today at 06:20 UTC, shares in Shreekrishna Biotech are trading at IN₹141.40. This share price information is delayed by 15 minutes.
Shares in Shreekrishna Biotech last closed at IN₹141.40 and the price had moved by +116.87% over the past 365 days. In terms of relative price strength the Shreekrishna Biotech share price has outperformed the S&P BSE 100 Index by +100.25% over the past year.
There is no consensus recommendation for this security.
Shreekrishna Biotech does not currently pay a dividend.
Shreekrishna Biotech does not currently pay a dividend.
Shreekrishna Biotech does not currently pay a dividend.
To buy shares in Shreekrishna Biotech you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of IN₹141.40, shares in Shreekrishna Biotech had a market capitalisation of .
Here are the trading details for Shreekrishna Biotech:
- Country of listing: India
- Exchange: BSE
- Ticker Symbol: 505592
Based on an overall assessment of its quality, value and momentum Shreekrishna Biotech is currently classified as a . The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We could not find analyst target price data for this security.
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Shreekrishna Biotech. Over the past six months, its share price has underperformed the S&P BSE 100 Index by -34.84%.
As of the last closing price of IN₹141.40, shares in Shreekrishna Biotech were trading matched their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Shreekrishna Biotech PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at IN₹141.40.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
We do not have data on Shreekrishna Biotech's directors